Understanding Cytokine Release Syndrome in COVID-19 Patients
Researchers detect aberrant cytokine activity in response to SARS-CoV-2 infection.
Variable host immune responses to SARS-CoV-2 lead to a range of symptoms and complications. Many of these associate with elevated circulating pro-inflammatory cytokines, which cause cytokine release syndrome (CRS). To better understand the host immune response against SARS-CoV-2 and CRS, scientists use multiplex cytokine panels to measure tens of cytokines at once.
Download this article from Bio-Rad to learn about using Bio-Plex cytokine panels to detect cytokines in COVID-19 patient samples.
